145303-69-1

Basic information

• Product Name: 1,2-Benzenedicarboxylic acid, 4,5-dichloro-, monomethyl ester
• CAS NO: 145303-69-1
• Molecular Formula: C9H6Cl2O4
• Molecular Weight: 249.05
• Mol File: 145303-69-1.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: 1,2-Benzenedicarboxylic acid, 4,5-dichloro-, monomethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-Benzenedicarboxylic acid, 4,5-dichloro-, monomethyl ester(145303-69-1)
• EPA Substance Registry System: 1,2-Benzenedicarboxylic acid, 4,5-dichloro-, monomethyl ester(145303-69-1)

Safety Data

• Hazardous Substances Data: 145303-69-1(Hazardous Substances Data)

Usage

Chemical structure

1,2-Benzenedicarboxylic acid, 4,5-dichloro-, monomethyl ester

Physical state

Clear and colorless liquid

Odor

Faint, fruity

Usage

Raw material for polymer production

Polymers produced

Polyethylene terephthalate (PET)

Applications

Plastic bottles, containers, polyester fibers, and films

Safety

Relatively safe for use

Potential hazard

Irritation to the respiratory system at high concentrations

Precautions

Proper handling and storage required to ensure safety and prevent hazards

Upstream product

• 942-06-3 4,5-dichlorophthalic anhydride 
• 124-41-4 sodium methylate 
• 67-56-1 methanol 

Downstream Products

• 60695-93-4 methyl 4,5-dichloro-2-(chlorocarbonyl)benzoate 
• 168893-61-6 2-(3-Amino-1H-1,2,4-triazol-5-yl)-4,5-dichlorobenzoic acid 
• 1256593-29-9 (Z)-methyl 4,5-dichloro-2-(2-cyanovinyl)benzoate 
• 1256593-27-7 (E)-methyl 4,5-dichloro-2-(2-cyanovinyl)benzoate 
• 1256593-25-5 methyl 4,5-dichloro-2-formylbenzoate 
• 844647-17-2 2-amino-4,5-dichloro-benzoic acid methyl ester 
• 880347-54-6 2-(benzo[1,2,5]thiadiazole-4-sulfonylamino)-4,5-dichloro-benzoic acid methyl ester 
• 1297599-49-5 2-(benzo[1,2,5]thiadiazole-4-sulfonylamino)-4,5-dichlorobenzoyl chloride 
• 880347-55-7 2-(benzo[1,2,5]thiadiazole-4-sulfonylamino)-4,5-dichlorobenzoic acid 

Relevant articles and documents

Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists II: Tuning of receptor selectivity and in vivo efficacy

In the previous article we demonstrated how certain CCK2R-selective anthranilic amides could be structurally modified to afford high-affinity, selective CCK1R activity. We now describe our efforts at modulating and optimizing the CCK1R and CCK2R affinitie

N-SUBSTITUTED-5-SUBSTITUTED PHTHALAMIC ACIDS AS SORTILIN INHIBITORS

The present invention is directed to N-substituted-5-substituted phthalamic acids which of formula (A). The compounds are considered useful for the treatment of diseases treatment of a neurodegenerative disease, psychiatric disease, motorneuron disease, peripheral neuropathies, pain, neuroinflammation or atherosclerosis such as Alzheimer's disease and Parkinson's disease.

MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF

The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I), wherein R1,R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.